Skip to main content
. 2021 Feb 24;29(9):5197–5207. doi: 10.1007/s00520-021-06059-2

Fig. 3.

Fig. 3

Two measures of neuropathy in patients who were switched to vinorelbine (n = 199). a Mean neuropathy scores at and after switch to vinorelbine. b Proportion of patients with worsening, stable, and improving neuropathy after switching to vinorelbine. c Correlation between neuropathy grades according to NCI CTC and TNS scores